Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Disease recurrence, Pain in extremity, SARS-CoV-2 test, Vaccination failure
Clinical narrative: reactions to shots other than sore arm; Rebound COVID; COVID-19 treatment; COVID-19 treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 74-year-old female patient received BNT162b2 (BNT162B2), on 01Feb2021 as dose 1, single (Lot number: EL3302), on 01Mar2021 as dose 2, single (Lot number: EN5318), on 09Oct2021 as dose 3 (booster), single (Lot number: 301308A) and on 09May2022 as dose 4 (booster), single (Lot number: FM9992) at the age of 74 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: Patient's Medical History (including any illness at time of, vaccination)? None; "Covid", start date: 2018 (unspecified if ongoing), notes: only for 24 hours. Shingles Shot; Shingrix; 2 shots before COVID so, 2018 Vaccination Date: long time ago. Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal; CALCIUM; IRON; D3; MULTIPLE VITAMINS. Vaccination history included: Shingles (only for 24 hours.Shingles Shot; Shingrix; 2 shots before COVID so, 2018 Vaccination Date: long time ago), for immunization, reaction(s): "feverish"; Shingles (Shingles Shot; Shingrix; 2 shots before COVID so, 2018 Vaccination Date: long time ago), for immunization, reaction(s): "fever". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "recovered" (Aug2022) and all described as "COVID-19 treatment"; DISEASE RECURRENCE (medically significant) with onset 18Aug2022, outcome "unknown", described as "Rebound COVID"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as " reactions to shots other than sore arm ". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Therapeutic measures were not taken as a result of disease recurrence.  Additional information: No other conditions was reported.No investigation was reported. Paxlovid treatment was given from 8Aug2022 to 13Aug2022. Paxlovid for Covid-19 and she had Covid rebound and her doctor told her she needed to call in and report. The rebound Covid started 18Aug2022. She hopes the rebound Covid is not ongoing and states she doesn't have any symptoms. She doesn't have the packaging anymore but has the paper work that the pharmacist attaches. She sees, Quantity 30 and manufacturer packaging; 150x2-100mg. She took for 5 days.No additional vaccines administered on same date of the pfizer suspect if applicable, list all vaccines administered on same date with the pfizer vaccine considered as suspect.No emergency room visit was reportd. No prior vaccinations (within 4 weeks) if applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was reported. patient medical history (including any illness at time of vaccination) was reported as none. Relevant tests was reported as none.